T
Dead / Cancelled — Cancelled — Section 8 (as of 24 Jun 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85007654
- Registration number
- 4071340
- Mark type
- Design + words
- Filed
- 06 Apr 2010
- Published for opposition
- 21 Sept 2010
- Registered
- 13 Dec 2011
- Attorney of record
- JOHN P. MURTAUGH
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation for the treatment of thyroid disease
Owner
- IBSA INSTITUT BIOCHIMIQUE S.A., CH-6903 LUGANO, CH
- IBSA INSTITUT BIOCHIMIQUE S.A., CH-6903 LUGANO, CH
- AKRIMAX PHARMACEUTICALS, LLC, Cranford, NJ, US
- AKRIMAX PHARMACEUTICALS, LLC, Cranford, NJ, US
Prosecution history
- 24 Jun 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 13 Dec 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Mar 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 20 Mar 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 20 Mar 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Feb 2017 — TEAS SECTION 8 RECEIVED
- 13 Dec 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Dec 2011 — REGISTERED-PRINCIPAL REGISTER
- 11 Nov 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Nov 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 09 Nov 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Oct 2011 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Oct 2011 — USE AMENDMENT FILED
- 19 Oct 2011 — TEAS STATEMENT OF USE RECEIVED
- 27 Sept 2011 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED